Showing results (221-230 of 105,852) with videos related to
Sort By:
Pageof 10,586
Clinical Therapeutics|December 22, 2005
Use of Monte Carlo simulation to assess the pharmacodynamics of beta-lactams against Pseudomonas aeruginosa infections in children: a report from the OPTAMA programJennifer M Ellis, Joseph L Kuti, David P NicolauAntimicrobial Agents and Chemotherapy|May 5, 2025
<i>Ex vivo</i> assessment and simulation to guide cefepime-taniborbactam dosing recommendations for patients receiving continuous renal replacement therapyAliaa Fouad, Cole McGrath, Ecem Buyukyanbolu, et al.Antimicrobial Agents and Chemotherapy|December 18, 2013
Clinical pharmacodynamics of antipseudomonal cephalosporins in patients with ventilator-associated pneumoniaShawn H MacVane, Joseph L Kuti, David P NicolauDiabetes Research and Clinical Practice|January 7, 1988
Casual blood glucose levels and prevalence of undiscovered diabetes mellitus in Lagos Metropolis NigeriansA E Ohwovoriole, J A Kuti, S I KabiawuPharmacotherapy|January 30, 2008
The current state of multidrug-resistant gram-negative bacilli in North AmericaAnthony M Nicasio, Joseph L Kuti, David P NicolauProteins|January 29, 2014
Structural insights into FRS2α PTB domain recognition by neurotrophin receptor TrkBLei Zeng, Miklos Kuti, Shiraz Mujtaba, et al.The Journal of Antimicrobial Chemotherapy|September 20, 2021
Levofloxacin pharmacodynamics against Stenotrophomonas maltophilia in a neutropenic murine thigh infection model: implications for susceptibility breakpoint revisionAndrew J Fratoni, David P Nicolau, Joseph L KutiJournal of Family & Reproductive Health|February 19, 2021
Infant Feeding Practice and Associated Factors Among HIV Positive Mothers at Health Institution of Shashemene Town, South EthiopiaMustafa Geleto Ansha, Kemal Ahmed Kuti, Selamawit Tesfaye TasewSurgical Infections|October 6, 2005
Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistanceSu Young Lee, Joseph L Kuti, David P NicolauConnecticut Medicine|June 2, 2005
When "S" does not mean success: the importance of choice of antibiotic and dose on clinical and economic outcomes of severe infectionEffie L Gillespie, Joseph L Kuti, David P NicolauPageof 10,586